Clarithromycin Dosage and Administration

Infection-Specific Dosing

The Centers for Disease Control and Prevention recommends 1 g per day in two divided doses for 7 days for adults with pertussis, and 15 mg/kg per day (maximum: 1 g per day) in 2 divided doses for 7 days for children over 1 month 1
For Helicobacter pylori infection, the standard triple therapy is 500 mg twice daily for 14 days (with PPI and amoxicillin or metronidazole), as recommended by the World Journal of Emergency Surgery 2, 3
For Mycobacterium avium complex, the recommended dosage is 500 mg twice daily with ethambutol (15 mg/kg daily) 4, 5
For Lyme disease, 500 mg twice daily for 14-21 days is recommended for patients intolerant to first-line agents, as suggested by the Clinical Infectious Diseases journal 6, 7

The American Academy of Pediatrics recommends 15 mg/kg/day divided into 2 doses (maximum 1 g/day) for children over 1 month, as stated in the MMWR Recommendations and Reports and Thorax journals 1, 8
For NTM infections in children 1 month-11 years, the recommended dosage is 7.5 mg/kg twice daily (max 500 mg per dose), according to the Thorax journal 8
Weight-based dosing for children 1 month-11 years is recommended, with specific dosages for different weight ranges, as outlined in the Thorax journal 8

Clarithromycin is contraindicated in patients with a history of hypersensitivity to macrolide antibiotics, as stated in the MMWR Recommendations and Reports 1
The drug should not be administered with astemizole, cisapride, pimazole, or terfenadine due to the risk of cardiac arrhythmias, as warned by the MMWR Recommendations and Reports 1
Clarithromycin inhibits cytochrome P450 (CYP3A) enzymes, leading to multiple potential drug interactions, as noted in the MMWR Recommendations and Reports 1
Common adverse effects include gastrointestinal symptoms, as reported in the Thorax journal 8

ECG monitoring is recommended at baseline and after 2 weeks for patients at risk of QT prolongation, as suggested by the Thorax journal 8
Audiometry is recommended at baseline and if symptoms of hearing loss develop, according to the Thorax journal 8
Routine monitoring of complete blood count, renal and liver function tests is recommended during treatment, as stated in the Thorax journal 8